secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2026-09-15T21:02:50+00:00
Accession:  0001213900-26-100185
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences Q1 FY27 net loss $3.2M; Fortitude merger closing in Q4 2026
-------------------------------------------------------------------------

- Net loss $3.2M in FQ1 2027 (ended 7/31/26) vs $2.1M year-ago; operating loss $2.9M; no meaningful revenue.
- All-stock merger with Fortitude (Zcash mining) expected to close Q4 2026; Fortitude added 9,000 Z15 Pro miners (~7.5 Gsol/s) and a 12.5MW Nebraska facility.
- MyoVista Insights platform: first US commercial agreements, version 1.4, selected by major European reference center; patent portfolio >45 granted.
- Recorded $0.3M inventory reserve for MyoVista wavECG device; no further commercialization planned; FDA 510(k) still under review.
- Since period end: raised ~$1.0M from Fortitude, ~$1.2M net ATM, exchanged $200K note for shares; shareholders' deficit $2.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026100185/0001213900-26-100185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026100185/ea0305626-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-100185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer